In this resource library we share documents, presentations, forms, videos and useful links from Pinnacle and the wider sector.
Use the search box and filters to help find what you're looking for or view all COVID-19 resources
Can't find what you need? Try searching in programmes.
Dr Jo Scott-Jones and Dr Dave Maplesden discuss adrenaline auto-injectors, a scam alert, a Goodfellow Gem about the effect of NSAIDs on post-fracture bone healing, and more.
Jo Scott-Jones and Dave Maplesden discuss ACC Integrated Care Pathways Musculoskeletal, Amoxicillin dosing in acute otitis media, Microplastics, nanoplastics and CVD risk, and more.
Dr Jo Scott-Jones and Dr Dave Maplesden discuss prescribing, concussion, a new emergency procedure for cardiac arrest known as double sequential external defibrillation (DSED), and more.
Dr Jo Scott-Jones and Dr Dave Maplesden discuss not using ACE and ARB and statin use in pregnancy, monitoring lithium drug interactions, shared care clozapine and more.
Dr Jo Scott-Jones and Dr Dave Maplesden discuss symmetrical drug-related intertriginous and flexural exanthema (SDRIFE), sodium valproate in people who can father children, accelerated silicosis and more.
Controlled drug changes took effect on 5 October 2023 with the gazetting of the Misuse of Drugs Amendment Regulations (No 2) 2023. The Amendment Regulations reduced the maximum limit for all opioid controlled drugs to one month. They align prescribing limits for electronic (NZePS) and physical prescriptions, and all controlled drug prescribers. The amendments do not affect the specific controlled drugs that certain groups are authorised to prescribe. Pinnacle continue to get questions about recent changes in controlled drug prescribing.
Dr Jo Scott-Jones and Dr Dave Maplesden discuss non-subsidised medications for beneficiaries, RNZCGP statement on medical cannabis prescribing, IFNAR1 deficiency, and more.
Dr Jo Scott-Jones and Dr Dave Maplesden discuss acne treatment, prescribing and burnout, medication withdrawals, and more.
Dr Jo Scott-Jones and Dr Dave Maplesden discuss assessing capacity (in activating enduring power of attorney), HPV screening, changes to opioid prescribing and more.
Dr Jo Scott-Jones and Dr Dave Maplesden discuss superficial venous thrombosis (thrombophlebitis), ACE inhibitors and angio-oedema, ammended Ivermectin Special Authority criteria, and more, in this month's clinical snippets.